GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)
Hong Kong · Delayed Price · Currency is HKD 33.00
+3.42 (11.56%)
Sep 30, 2026, 4:08 PM HKT
HKG:2595 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Net Income | -1,316 | -1,795 | -677.64 | -508.32 |
Depreciation & Amortization | 8.77 | 9.58 | 13.94 | 17.67 |
Other Amortization | 0.32 | 0.18 | 0.18 | 0.19 |
Loss (Gain) From Sale of Assets | 0.03 | 0.01 | 0.01 | 0.14 |
Loss (Gain) From Sale of Investments | -3.96 | -0.08 | -0.4 | -3.59 |
Stock-Based Compensation | 26.31 | 26.28 | 26.94 | 36.97 |
Other Operating Activities | 962.22 | 1,543 | 395.18 | 253.63 |
Change in Accounts Receivable | 82.36 | 93.23 | -36.8 | -32.95 |
Change in Inventory | -0.08 | -11.75 | -3.53 | 0.54 |
Change in Accounts Payable | -49.53 | 48.14 | 156.14 | 7.76 |
Change in Unearned Revenue | 0.17 | -24.03 | -60.21 | 11.21 |
Change in Other Net Operating Assets | -79.4 | -25.8 | -20.2 | 14.69 |
Operating Cash Flow | -368.89 | -135.7 | -206.4 | -202.06 |
Operating Cash Flow Growth | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Capital Expenditures | -3.79 | -0.11 | -0.24 | -0.59 |
Sale of Property, Plant & Equipment | 0.07 | 0.07 | 0 | 0.01 |
Sale (Purchase) of Intangibles | -1.76 | -0.01 | -0.03 | - |
Investment in Securities | -1,191 | -825.44 | 0.99 | 264.02 |
Investing Cash Flow | -1,196 | -825.48 | 0.73 | 263.44 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Short-Term Debt Issued | - | 88.9 | 56.93 | 5.31 |
Total Debt Issued | 127.45 | 88.9 | 56.93 | 5.31 |
Short-Term Debt Repaid | - | -56.13 | -11.11 | -22.77 |
Long-Term Debt Repaid | - | -4.78 | -5.14 | -5.4 |
Lease Payments | -5.31 | -4.78 | -5.14 | -5.4 |
Total Debt Repaid | -87.31 | -60.91 | -16.26 | -28.17 |
Net Debt Issued (Repaid) | 40.14 | 27.99 | 40.67 | -22.86 |
Issuance of Common Stock | 1,820 | 1,820 | 207.87 | - |
Other Financing Activities | -15.23 | -15.18 | -15.11 | -6.2 |
Financing Cash Flow | 1,845 | 1,833 | 233.44 | -29.06 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Foreign Exchange Rate Adjustments | -57.75 | -36.62 | 2.16 | 4.55 |
Net Cash Flow | 222.54 | 835.32 | 29.93 | 36.88 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -372.68 | -135.81 | -206.64 | -202.65 |
Free Cash Flow Growth | - | - | - | - |
Free Cash Flow Margin | -443.69% | -104.25% | -197.35% | -274.85% |
Free Cash Flow Per Share | -0.80 | -0.46 | -0.80 | -0.92 |
Levered Free Cash Flow | -3,027 | -2,214 | 407.96 | - |
Unlevered Free Cash Flow | -3,024 | -2,211 | 411.79 | - |
Free Cash Flow After Leases | -377.99 | -140.59 | -211.78 | -208.06 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash Interest Paid | 3.33 | 3.1 | 1.99 | 1.49 |
Cash Income Tax Paid | 0.13 | 0.15 | - | - |
Change in Working Capital | -46.48 | 79.8 | 35.4 | 1.27 |